In recent months, weight loss medication such as Ozempic, Wegovy and Mounjaro has gained popularity as an option for treating overweight and obesity. These drugs, originally prescribed for patients with type 2 diabetes, act on the mechanisms that regulate appetite and feelings of fullness. Their effect is based on reducing hunger and improving blood glucose control, which can facilitate weight loss in certain patients. However, these are relatively new medications and should always be used under medical supervision.
Although they can be a useful tool in specific cases, they are not without risks. Possible side effects include digestive discomfort, nausea, fatigue and excessive appetite suppression. In addition, when treatment is discontinued without real lifestyle changes, a rebound effect is common, leading to partial or total weight regain. For this reason, these medications should not be considered a standalone solution, but rather part of a comprehensive approach.
One of the main risks of rapid weight loss with this type of medication is the loss of muscle mass, especially if the process is not accompanied by strength training and adequate protein intake. A lower number on the scale does not always mean an improvement in body composition, and muscle loss can negatively affect metabolism and increase the risk of future weight regain.
At Clínica Torrubia Garbayo, a personalized medical assessment is carried out to determine whether this type of treatment is appropriate for each patient. The goal is not only weight loss, but achieving it in a safe and sustainable way while prioritizing metabolic and muscular health. Medication can be a helpful tool, but it never replaces a comprehensive medical approach based on healthy habits, nutrition and professional follow-up.